Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Jul 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.1M
Net Open-Market Flow
-$5.1M
Transactions
13
12 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2026Option exercise(M)10K$135.42$1.3M334K
Jul 17, 2026Sell(S)240$528.91$127K334K
Jul 17, 2026Sell(S)240$530.83$127K333K
Jul 17, 2026Sell(S)720$534.57$385K333K
Jul 17, 2026Sell(S)2K$535.53$1.3M330K
Jul 17, 2026Sell(S)2K$536.36$1.1M328K
Jul 17, 2026Sell(S)1K$537.45$623K327K
Jul 17, 2026Sell(S)423$538.70$228K327K
Jul 17, 2026Sell(S)821$539.63$443K326K
Jul 17, 2026Sell(S)251$540.69$136K326K
Jul 17, 2026Sell(S)892$542.06$484K325K
Jul 17, 2026Sell(S)293$542.43$159K324K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 17, 2026Option exercise(M)10K$0322K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000101) within minutes of acceptance. Every field above traces to the original document. Verify it directly: